Search For "pharma"
Pharma factory in Tamil Nadu probed after 9 children die from consuming co
Updated : 5 months, 1 week ago IST
The probe was initiated after Madhya Pradesh State Food and Drug Controller Dinesh Kumar Maurya requested the Tamil Nadu State Drug Control Department to inspect and take action against the Srisan Pharmaceutical Factory located in Kancheepuram.
Read More
Death toll rises to 9 in Madhya Pradesh Chhindwara cough syrup consumption
Updated : 5 months, 1 week ago IST
The death toll of children in the suspected cough syrup consumption case in Madhya Pradesh's Chhindwara district has risen to nine, said Dr Pawan Nandurkar, Associate Professor and Head of Paediatrics at Nagpur Medical College.
Read More
Cough syrup linked to deaths of Chhindwara children sent for lab testing
Updated : 5 months, 1 week ago IST
Samples of a cough syrup linked to the deaths of several children have been collected from a pharmaceutical unit in Jabalpur on Friday and are sent for laboratory testing, said Drug Inspector Sharad Kumar Jain.
Read More
South Korean shipping stocks weaken on tariff worries
Updated : 5 months, 1 week ago IST
South Korean shipping stocks fell on Tuesday as investors fretted over a prolonged global trade slowdown tied to U.S. tariff policies, while Hanmi Pharmaceutical rose after announcing a technology transfer deal with Gilead Sciences, the Pulse, the English service of Maeil Business Newspaper
Read More
Two Years of Bajaj Finserv Flexi Cap Fund: Understanding its Unique Invest
Updated : 5 months, 1 week ago IST
Pune (Maharashtra) [India], September 29: Since its launch in August 2023, the Bajaj Finserv Flexi Cap Fund has grown steadily, reaching Assets Under Management (AUM) of Rs. 5,410.04 crore as of August 31, 2025. The fund has delivered a Compound Annual Growth Rate (CAGR) of 19.19%* under the
Read More
Healthcare Fund Explained: Understanding Sector-focused Investing
Updated : 5 months, 1 week ago IST
Pune (Maharashtra) [India], September 29: Investors often look for ways to participate in sectors that may offer long-term growth potential. A healthcare fund may provide exposure to companies in the healthcare industry, including pharmaceuticals, hospitals, and biotechnology firms.
Read More
Nifty, Sensex open flat amid US tariff pressure, IPO openings to keep mark
Updated : 5 months, 1 week ago IST
The stock market opened flat in green on Monday after a sharp correction last week, as investor sentiment remained weak due to U.S. President Donald Trump's tariff policies on pharma and their impact on India.
Read More
"Closely monitoring, examining impact": MEA on Trump's announcement to imp
Updated : 5 months, 1 week ago IST
The Ministry of External Affairs stated on Friday that India is closely monitoring the impact of US President Donald Trump's announcement to impose tariffs of up to 100% on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.
Read More
Shimla patients get relief as new GST reforms reduce medicine prices by up
Updated : 5 months, 2 weeks ago IST
The Pharmaceutical companies and chemists in Shimla have begun implementing the revised GST night tariff on medicines, bringing much-needed relief to patients and the poor.
Read More
"BJP's failure that our businesses, trade and nation suffering": Akhilesh
Updated : 5 months, 2 weeks ago IST
Samajwadi Party chief Akhilesh Yadav on Friday termed Bharatiya Janata Party's foreign policy a "failure", blaming the government for the "suffering" of India's businesses and trade due to the tariffs imposed by the US.
Read More
European drugmakers to bear brunt of new U.S. tariffs, India less exposed:
Updated : 5 months, 1 week ago IST
European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI).
Read More
100% US tariffs on branded pharma imports not likely to affect Indian gene
Updated : 5 months, 1 week ago IST
India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA).
Read More